Rocket Pharmaceuticals, Inc.
Rocket Pharmaceuticals, Inc. (RCKT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · RCKT · as of Jun 8, 2026
Key Statistics
Explore Rocket Pharmaceuticals, Inc. Data
rckt stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 19 · Buy rate: 68.4%
The RCKT analyst consensus is Buy, based on ratings from 19 Wall Street analysts over the past 3 months. The average 12-month price target is $5.00, representing +86.22% upside from the current price of $2.69.
Competitors & Peers
rckt competitorsRCKT
ANNX
AURA
AUTL
DBVT
DSGNStock Performance
Full HistoryAbout Rocket Pharmaceuticals, Inc.
Rocket Pharmaceuticals, Inc. together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has thr…
what is rocket pharmaceuticals, inc. · rckt stock overview · rocket pharmaceuticals, inc. company profile · who is rocket pharmaceuticals, inc. ceo · rckt NASDAQ · rocket pharmaceuticals, inc. headquarters · rocket pharmaceuticals, inc. business segments
About Stock Overview & Key Data
Rocket Pharmaceuticals, Inc. (RCKT) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Feb 18, 2015. As of the latest trading session, RCKT stock price is $2.69, with a market capitalization of $293.0M. The stock has returned -11.16% over the past 12 months and -23.56% year-to-date.
According to 19 Wall Street analysts, the consensus rating for Rocket Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $5.00. In fiscal year 2025, Rocket Pharmaceuticals, Inc. reported revenue of — and net income of -$223.1M. For detailed data — including Rocket Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Rocket Pharmaceuticals, Inc. (RCKT) stock price is $2.69. The stock is traded on NASDAQ under the ticker symbol RCKT. The 52-week range is $2.40 – $5.45.